Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 5;4(2):424-435.
doi: 10.1021/acsptsci.1c00014. eCollection 2021 Apr 9.

Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects

Affiliations
Review

Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects

Jacob S Aday et al. ACS Pharmacol Transl Sci. .

Abstract

Psychedelic drugs are increasingly being incorporated into therapeutic contexts for the purposes of promoting mental health. However, they can also induce adverse reactions in some individuals, and it is difficult to predict before treatment who is likely to experience positive or adverse acute effects. Although consideration of setting and dosage as well as excluding individuals with psychotic predispositions has thus far led to a high degree of safety, it is imperative that researchers develop a more nuanced understanding of how to predict individual reactions. To this end, the current systematic review coalesced the results of 14 studies that included baseline states or traits predictive of the acute effects of psychedelics. Individuals high in the traits of absorption, openness, and acceptance as well as a state of surrender were more likely to have positive and mystical-type experiences, whereas those low in openness and surrender or in preoccupied, apprehensive, or confused psychological states were more likely to experience acute adverse reactions. Participant sex was not a robust predictor of drug effects, but 5-HT2AR binding potential, executive network node diversity, and rACC volume may be potential baseline biomarkers related to acute reactions. Finally, increased age and experience with psychedelics were individual differences related to generally less intense effects, indicating that users may become slightly less sensitive to the effects of the drugs after repeated usage. Although future well-powered, placebo-controlled trials directly comparing the relative importance of these predictors is needed, this review synthesizes the field's current understanding of how to predict acute reactions to psychedelic drugs.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following competing financial interest(s): Dr. Davis is a board member of Source Research Foundation. This organization was not involved in the design/execution of this study or the interpretation or communication of findings.

Figures

Figure 1
Figure 1
Flow diagram depicting the systematic search process.

Similar articles

Cited by

References

    1. U.S. Navy . (1967) LSD [TV broadcast], U.S. Navy Training Film.
    1. CBS . (2019, October 13) Researchers experimenting with psychedelics to treat addiction. Depression and anxiety, 60 Minutes [TV series episode].
    1. Davis A. K.; Barrett F. S.; Griffiths R. R. (2020) Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. J. Contex Behav Sci. 15, 39–45. 10.1016/j.jcbs.2019.11.004. - DOI - PMC - PubMed
    1. Roseman L.; Haijen E.; Idialu-Ikato K.; Kaelen M.; Watts R.; Carhart-Harris R. L. (2019) Emotional breakthrough and psychedelics: Validation of the emotional breakthrough inventory. J. Psychopharmacol. 33, 1076–1087. 10.1177/0269881119855974. - DOI - PubMed
    1. Carhart-Harris R. L.; Erritzoe D.; Williams T.; Stone J. M.; Reed L. J.; Colasanti A.; Tyacke R. J.; Leech R.; Malizia A. L.; Murphy K.; et al. (2012) Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc. Natl. Acad. Sci. U. S. A. 109, 2138–2143. 10.1073/pnas.1119598109. - DOI - PMC - PubMed